Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis

Author： Ose Leiv   Shah Arvind   Davies Michael J.   Rotonda Jennifer   Maccubbin Darbie   Tribble Diane   Veltri Enrico   Mitchel Yale  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.22, Iss.5, 2006-05, pp. : 823-835

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual cholesterol inhibition with ezetimibe/simvastatin in pre-treated hypercholesterolaemic patients with coronary heart disease or diabetes mellitus: prospective observational cohort studies in clinical practice

By Hildemann Steven K.   Barho Christian   Karmann Barbara   Darius Harald   Bestehorn Kurt  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 713-719

Informa Healthcare

Access to resources Recommend Favorite

Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients

By Catapano Alberico L.   Davidson Michael H.   Ballantyne Christie M.   Brady William E.   Gazzara Russell A.   Tomassini Joanne E.   Tershakovec Andrew M.  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2041-2053

Informa Healthcare

Access to resources Recommend Favorite

Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials

By Catapano Alberico   Brady William E.   King Thomas R.   Palmisano Joanne  

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 1123-1130

Informa Healthcare

Access to resources Recommend Favorite

The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia

By Florentin Matilda   Liberopoulos Evangelos N.   Moutzouri Elisavet   Rizos Christos V.   Tselepis Alexandros D.   Elisaf Moses S.  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 685-692

Informa Healthcare

Access to resources Recommend Favorite

Underutilization of Measurement of Serum Low‐Density Lipoprotein Cholesterol Levels and of Lipid‐Lowering Therapy in Older Patients with Manifest Atherosclerotic Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 9, 1998-09 ,pp. : 1128-1131

John Wiley & Sons Inc

Access to resources Recommend Favorite